Literature DB >> 8390242

Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

F Imamura1, T Horai, M Mukai, K Shinkai, M Sawada, H Akedo.   

Abstract

Serum is known to be required for invasion or phagokinesis of certain tumor cells, although the mechanism of its action is not well understood yet. In the in vitro invasion assay system we have developed, MM1 cells exhibiting extensive invasiveness against cultured mesothelial cell monolayers in the presence of 10% fetal calf serum did not invade them without serum. Human small cell lung cancer (OC10) cells also required serum in invasion. Serum could be completely substituted by oleoyl-lysophosphatidic acid (LPA) or bacterial phospholipase D (PLD). Phosphatidic acid also had an invasion-inducing activity, though to a lesser degree. Since human ovarian cancer (RMUG-S) cells require neither serum, LPA nor the PLD for invasion of mesothelial cell monolayers, the production of phospholipid like LPA, a candidate for intracellular second messenger, in tumor cells seems critical for the invasion by MM1 cells or OC10 cells. This result suggests a possible participation of particular signaling cascade, PLD-LPA(PA) system, in the invasion of certain tumor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390242     DOI: 10.1006/bbrc.1993.1651

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

Review 2.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

3.  Increased phospholipase D activity in human breast cancer.

Authors:  N Uchida; S Okamura; Y Nagamachi; S Yamashita
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 5.  Optochemical Control of Biological Processes in Cells and Animals.

Authors:  Nicholas Ankenbruck; Taylor Courtney; Yuta Naro; Alexander Deiters
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-01       Impact factor: 15.336

6.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

7.  Down-regulation of focal adhesion kinase, pp125FAK, in endothelial cell retraction during tumor cell invasion.

Authors:  H Okamoto; S Nakamori; M Mukai; K Shinkai; H Ohigashi; O Ishikawa; H Furukawa; S Imaoka; Y Matumoto; M Monden; H Akedo
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

8.  Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.

Authors:  Z Guo; K Liliom; D J Fischer; I C Bathurst; L D Tomei; M C Kiefer; G Tigyi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

9.  Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.

Authors:  Hironobu Yamashita; Manisha Tripathi; Jerome Jourquin; Yoonseok Kam; Shanshan Liu; Brandy Weidow; Vito Quaranta
Journal:  J Oncol       Date:  2010-08-25       Impact factor: 4.375

10.  Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma.

Authors:  A Tokumura; M Miyake; O Yoshimoto; M Shimizu; K Fukuzawa
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.